[HTML] springer.com

[HTML][HTML] Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - Springer
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …
被引用次数：27 相关文章

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - search.ebscohost.com
Objectives: To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …
[HTML] nih.gov

[HTML][HTML] Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - ncbi.nlm.nih.gov
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …
[PDF] academia.edu

[PDF][PDF] Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - academia.edu
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …
[PDF] archive.org

[PDF][PDF] Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - scholar.archive.org
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - europepmc.org
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance. A retrospective cohort study

T Ullrich, C Arsov, D Mally, A Hiester, P Albers… - European …, 2020 - inis.iaea.org
[en] To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude prostate
cancer (PCa) progression during monitoring patients on active surveillance (AS). One …

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.

T Ullrich, C Arsov, M Quentin, F Mones… - European …, 2020 - europepmc.org
Objectives To assess the ability of multiparametric MRI (mp-MRI) of the prostate to exclude
prostate cancer (PCa) progression during monitoring patients on active surveillance (AS) …